We are investigating whether tezepelumab can help adults with moderate to very severe COPD experience fewer flare-ups and improve their lung function and quality of life compared to a placebo.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes it hard to breathe, often caused by long-term exposure to irritants like cigarette smoke. Symptoms include persistent cough, shortness of breath, and wheezing.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
